850012-53-2

Usage

Uses

Used in Organic Synthesis:
1-(4-Bromo-2-tert-butyl-phenyl)-pyrrolidine is used as an intermediate in organic synthesis for [application reason]. Its unique structure allows for the creation of various complex molecules that can be utilized in different fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(4-Bromo-2-tert-butyl-phenyl)-pyrrolidine is used as a key compound in drug discovery and development for [application reason]. Its structural properties make it a promising candidate for the design and synthesis of new therapeutic agents.
Used in Drug Discovery and Development:
1-(4-Bromo-2-tert-butyl-phenyl)-pyrrolidine is used as a building block in drug discovery and development for [application reason]. Its specific functional groups and structural features can be exploited to create novel drug candidates with potential therapeutic applications.

Upstream product

• 850012-44-1 4-bromo-(2-tert-butyl)aniline 
• 110-52-1 1,4-dibromo-butane 

Downstream Products

• 895542-09-3 3″-tert-butyl-4′-(2-hydroxy-ethoxy)-4″-pyrrolidin-1-yl-[1,1′;3′,1″]-terphenyl-4-carboxylic acid 
• 895543-00-7 (3-(tert-butyl)-4-(pyrrolidin-1-yl)phenyl)boronic acid 

Relevant academic research and scientific papers

PREPARATION OF TRIFAROTENE AND INTERMEDIATES AND POLYMORPHS THEREOF

The present disclosure provides a process for the preparation of Trifarotene. The disclosure also provides novel intermediates in the process described herein. Also provided are novel polymorphs of Trifarotene.

NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS

The invention relates to compounds corresponding to general formula (I) below: to the compositions containing same, to methods for the preparation thereof and to the use thereof in pharmaceutical compositions for use in human or veterinary medicine, or else in cosmetic compositions.

Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors

Novel ligand compounds that activate RAR receptors have the following structural formula (I): and are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions.

NOVEL LIGANDS THAT MODULATE RAR RECEPTORS, AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS

The present invention relates to novel compounds corresponding to the general formula (I) below: to compositions containing them, to processes for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medic